Читать книгу Biologics, Biosimilars, and Biobetters - Группа авторов - Страница 89

Remicade^® was originally developed by Centocor Ortho Biotech, which is now Janssen Biotech, a Johnson & Johnson subsidiary.

Indications: Rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, ulcerative colitis

Manufacturer: Johnson & Johnson/Merck & Co.

Global Sales in 2017: US$7.1 billion

Generic name: Infliximab

Launch date: 1998